The main conclusion place was the security and tolerability of sifalimumab. Therapy-emergent adverse functions (AEs) and critical AEs (SAEs) as well as their severity, consequence, and any partnership for the research medication had been recorded because of the investigator through the study. AEs were regarded as likely to be linked https://immanuelu000jvh3.empirewiki.com/user